Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Para A of Part A of Schedule III thereto, we wish to inform you that the Audit Committee at its meeting today, i.e. 21st October, 2026, has approved the initiation of forensic audit in connection with a recent incident involving alleged misappropriation of funds by a former employee of the Company, for examining the facts and circumstances ....

21st October, 2026 The Corporate Relationship Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Bandra East, Mumbai 400 001. Mumbai 400 051. Scrip Code: 539523 Scrip Symbol: ALKEM Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended (“SEBI LODR Regulations”) – Intimation regarding initiation of Forensic Audit. Dear Sir(s)/ Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Para A of Part A of Schedule III thereto, we wish to inform you that the Audit Committee at its meeting today, i.e. 21st October, 2026, has approved the initiation of forensic audit in connection with a recent incident involving alleged misappropriation of funds by a former employee of the Company, for examining the facts and circumstances relating to the incident, determining the root cause and recommending appropriate corrective measures. Details as required under SEBI LODR Regulations read with SEBI Circular No. HO/49/14/14(7)2025- CFD-POD2/I/3762/2026 dated 30th January, 2026 are as follows: Particulars Disclosure Name of the entity Grant Thornton Bharat LLP initiating the forensic audit Reason for initiating the To assist in performing a preliminary ESI (electronically stored forensic audit information) review and market intelligence over procurement done by a former employee of the Company and independently investigate the suspected irregularities in certain transactions affecting the Company, for ascertaining the facts and circumstances and recommending corrective measures. A copy of this disclosure will be made available on the Company’s website in accordance with Regulation 30(8) of the SEBI LODR Regulations. Request you to kindly take the same on record. Sincerely, For Alkem Laboratories Limited Manish Narang President – Legal, Company Secretary & Compliance Officer